ARK Invest, led by Cathie Wood, made significant portfolio moves during the week ended July 10, increasing exposure across technology, healthcare, and digital asset sectors.
Space Exploration Technologies (NASDAQ: SPCX) represented the firm’s largest purchase by value, with approximately $52.1 million deployed across multiple ARK exchange-traded funds.
The heavy investment in SPCX signals ARK’s continued conviction in the commercial space sector as competition and innovation in the industry accelerate heading into the second half of 2026.
ARK also added shares of Eli Lilly (NYSE: LLY), reflecting the firm’s sustained interest in healthcare innovation, particularly within the high-growth pharmaceutical space.
Meta Platforms (NASDAQ: META) was another notable addition, consistent with ARK’s ongoing focus on artificial intelligence-driven businesses and next-generation digital infrastructure.
The firm also bought into X-Energy (NASDAQ: XE), Coinbase Global (NASDAQ: COIN), and Circle Internet Group (NYSE: CRCL), pointing to continued appetite for cryptocurrency-related and clean energy investments.
On the selling side, ARK reduced its holdings in Advanced Micro Devices (NASDAQ: AMD), Roku (NASDAQ: ROKU), and Robinhood Markets (NASDAQ: HOOD), trimming positions in names that have seen strong recent performance.
ARK also cut its stake in Deere (NYSE: DE) and Iridium Communications (NASDAQ: IRDM) as part of what appears to be a broader portfolio rebalancing effort.
The genomics sector saw notable reductions, with ARK trimming positions in Natera, Illumina, Twist Bioscience, 10x Genomics, and BioNTech across its funds.
The portfolio reshuffling comes as Wall Street prepares for the second-quarter earnings season, a period when many institutional managers adjust holdings to reflect updated growth outlooks and risk assessments.
ARK’s moves suggest a deliberate rotation away from semiconductors and genomics toward space, AI platforms, and digital finance, reinforcing the firm’s long-held thematic investment philosophy.
